On September 4, 2026, Boston Medical Sciences, Inc. was selected as a recipient of support under the Tokyo Metropolitan Government’s “Support for the Development of Medical Devices for Overseas Markets Based on Local Needs” (abbreviated as “SMEDO”) program for the 2026 fiscal year.
Read the full press release here.